Multi-modal cancer therapy using viral hitchhiking

Cancer therapies based on immunological methods are a rapidly expanding field of cancer treatment options. However, one major problem immunebased cancer therapies face is that cancer cells manage to escape immunological control during their evolution. Methods enabling the immune system to rerecognize tumor cells are therefore an essential part of immune cancer therapies. The present invention is based on a fusion protein that substantially enhances the tumordestroying effect of T-cells against tumor cells marked with Newcastle disease virus (NDV).

Further Information: PDF

DKFZ (German Cancer Research Center, Deutsches Krebsforschungszentrum)
Phone: +49-6221-42 2955

Contact
Dr. Ruth Herzog

Media Contact

info@technologieallianz.de TechnologieAllianz e.V.

All latest news from the category: Technology Offerings

Back to home

Comments (0)

Write a comment

Newest articles

Combatting disruptive ‘noise’ in quantum communication

In a significant milestone for quantum communication technology, an experiment has demonstrated how networks can be leveraged to combat disruptive ‘noise’ in quantum communications. The international effort led by researchers…

Stretchable quantum dot display

Intrinsically stretchable quantum dot-based light-emitting diodes achieved record-breaking performance. A team of South Korean scientists led by Professor KIM Dae-Hyeong of the Center for Nanoparticle Research within the Institute for…

Internet can achieve quantum speed with light saved as sound

Researchers at the University of Copenhagen’s Niels Bohr Institute have developed a new way to create quantum memory: A small drum can store data sent with light in its sonic…

Partners & Sponsors